§ The providers
Who sells what — and who to trust.

An independent overview of the compounded-GLP-1 telehealth market and the providers we cover — market size, what the FDA changed, and an honest read on each.

View the provider overviewOverview & reviews
§ Learn
The educational layer, in progress.

Primers for newcomers and deep dives for the curious. The foundation articles are published; more are in the pipeline.

View all Learn articles
§ The library · 19 articles · 6 live

Peptide therapy, explained.

Primers and deep dives, written for adults who want the honest version — with citations to original sources, not marketing copy.

§ 01 / Browse by topic

Three working categories.

02
2 of 7 live

Compounding and regulation

The legal architecture — 503A and 503B, FDA Category 2, state-by-state rules, finding a legitimate pharmacy.

03
1 of 7 live

Safety and dosing

Side effects, dosing protocols, injection technique, storage, and cycling. The practical mechanics.

  • Is peptide therapy safe?
  • Peptide safety
  • Side effects
  • Dosing basics
  • Injection technique
  • Storage and handling
  • Peptide cycling
§ 02 / All articles

Every article, A to Z.

6 live
of 19 planned
Article Type Read time
5
503A vs 503B compounding
Guide Planned
A
Primer 21 min
C
Deep dive 13 min
D
Dosing basics
Guide Planned
F
FDA Category 2 explained
Guide Planned
H
Primer 10 min
How to find a legitimate provider
Guide Planned
I
Injection technique
Guide Planned
Guide 12 min
P
Peptide cycling
Guide Planned
Peptide legality
Guide Planned
Peptide safety
Guide Planned
Peptides 101
Primer Planned
R
Red flags to avoid when buying
Guide Planned
Research peptides vs prescribed
Primer Planned
S
Side effects
Guide Planned
Guide 6 min
Storage and handling
Guide Planned
W
Primer 12 min
§ The Daily

The peptide brief, delivered.

A 5-minute daily digest on peptide therapy news, provider updates, and regulatory changes.

Find your peptide Take 60-sec quiz